mRNA technology changed the world during the pandemic, but it was thought to only be effective against viruses. Until now.
In a major scientific first, researchers at Tel Aviv University and the Israel Institute for Biological Research have developed an mRNA vaccine that provides 100% protection against a deadly bacterial infection in preclinical trials.
Bacteria are biologically complex, making it difficult for previous mRNA tech to target them. By overcoming this hurdle, these scientists haven't just created a potential vaccine for the plague (Yersinia pestis); they have opened a new frontier in medicine.
This breakthrough offers a powerful new weapon in the critical global fight against antibiotic-resistant "superbugs."
A monumental step forward for preventative medicine.
Sem comentários:
Enviar um comentário